• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    BIND Therapeutics, Inc. (BIND)

    -NasdaqGS
    5.49 Up 0.07(1.29%) Mar 27, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.42
    Open:5.46
    Bid:5.15 x 300
    Ask:5.69 x 500
    1y Target Est:16.00
    Beta:N/A
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:5.37 - 5.58
    52wk Range:4.89 - 13.72
    Volume:161,258
    Avg Vol (3m):915,719
    Market Cap:111.95M
    P/E (ttm):N/A
    EPS (ttm):-1.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BIND

    Comparison

    Symbol% ChgMkt Cap
    BINDUp 1.29%111.95M
    BMYUp 0.40%108.47B
    PGNXUp 1.40%403.21M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):10.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.08
    Quarterly EPS Est (Mar-15) :-0.55
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback